Islet cell autoimmunity and mitochondrial DNA mutation in Korean subjects with typical and atypical Type I diabetes

Diabetologia

Volumn 44, Issue 12, 2001, Pages 2187-2191

  Lee, W J ^a   Lee, H W ^b   Palmer, J P ^c   Park, K S ^d   Lee, H K ^d   Park, J Y ^a   Hong, S K ^a   Lee, K U ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Seoul National University   (South Korea)

Author keywords

Anti GAD antibody; Anti ICA512 antibody; Islet cell antibody; Mitochondrial DNA mutation; Type I diabetes mellitus

Indexed keywords

AUTOANTIBODY; C PEPTIDE; INSULIN; MITOCHONDRIAL DNA; PANCREAS ISLET CELL ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; IMMUNOFLUORESCENCE; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; KOREA; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET CELL; POINT MUTATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; AUTOIMMUNITY; CHILD; DIABETES MELLITUS, TYPE 1; DNA, MITOCHONDRIAL; FEMALE; GENE FREQUENCY; HUMANS; ISLETS OF LANGERHANS; KOREA; MALE; MIDDLE AGED; POINT MUTATION;

EID: 0035672475     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100028     Document Type: Article

References (32)

1. Immunogenetic and clinical characterization of slowly progressive IDDM
2. Clinical heterogeneity of insulin dependent diabetes mellitus in Korea
3. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease
4. Report of the expert committee on the diagnosis and classification of diabetes mellitus
5. 65-auto-antibodies in new-onset IDDM patients and help predict impending diabetes in their siblings
6. IA-2 antibodies - A sensitive marker of IDDM with clinical onset in childhood and adolescence
7. Maternal inherited diabetes-deafness of the young (MIDDY); A new mitochondrial syndrome
8. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness
9. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA
10. Mitochondrial gene mutation and insulin-deficient type of diabetes mellitus
11. Prevalence of maternally inherited diabetes and deafness in diabetic populations in the Netherlands
12. Leu(UUR) gene mutation in Japanese patients
13. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA
14. The high prevalence of the diabetic patients with a mutation in the mitochondrial gene in Japan
15. Maternally inherited diabetes and deafness: A diabetic subtype associated with a mutation in mitochondrial DNA
16. Fasting plasma C-peptide, glucagons stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes
17. Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables
18. Glucagon-stimulated and postprandial plasma C-peptide values as measures of insulin secretory capacity
19. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: Observation during eligibility testing for the diabetes control and complications trial
20. Effect of intensive insulin therapy on residual beta-cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial
21. C-peptide response to glucagon: A test for the residual beta-cell function in diabetes mellitus
22. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: The World Health Organisation multinational study of vascular disease in diabetics
23. Past and current obesity in Koreans with non-insulin-dependent diabetes mellitus
24. Epidemiology and natural history of NIDDM: Non-obese and obese
25. The frequency of ICA and anti-GAD antibody in Korean IDDM and NIDDM patients
26. Islet cell antibodies identify latent type 1 diabetes in patients 35-75 years at diagnosis
27. The low prevalence of immunogenetic markers in Korean adult-onset NIDDM patients
28. Geographic differences in the risk of insulin-dependent diabetes mellitus: The importance of registries
29. The incidence of IDDM in Seoul from 1985 to 1988
30. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies
31. Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics